Bronchial Diseases  >>  levocetirizine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levocetirizine / Generic mfg.
NCT00160563: Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

Terminated
3
207
Europe, RoW
LEVOCETIRIZINE, Xyzal®, Placebo
UCB Pharma
Asthma
03/06
03/06
NCT00152464: Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Completed
3
514
NA
Placebo, Levocetirizine, Xyzal
UCB Pharma SA
Dermatitis, Atopic
03/06
03/06

Download Options